Moaath Mustafa Ali1, Machelle Moeller2, Lisa Rybicki3, Halle C F Moore4. 1. Internal Medicine, Cleveland Clinic, Cleveland, OH, USA. 2. Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave, R35, Cleveland, OH, 44195, USA. 3. Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA. 4. Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave, R35, Cleveland, OH, 44195, USA. mooreh1@ccf.org.
Abstract
PURPOSE: Survivorship care is an essential component in the management of cancer patients. Optimal delivery of survivorship care requires an understanding of patient concerns and factors associated with treatment-related symptoms and comorbidities. METHODS: We conducted a retrospective cohort study evaluating 34 patient-reported conditions (symptoms and comorbidities) as well as self-reported health habits of stage 0-III breast cancer patients using a questionnaire completed at the time of the initial survivorship visit (SV). Logistic regression analysis was used to assess effects of treatment, age, body mass index, health habits, and timing of SV on these 34 conditions. RESULTS: Data from 1126 patients seen between April 2009 and November 2015 were analyzed. Hot flashes/night sweats (44%) and numbness/tingling (34%) were the most commonly reported conditions. Significant associations (P < 0.05) were observed with chemotherapy and increased prevalence of 26 conditions, as well as higher BMI and increased prevalence of 10 conditions. Age and timing of SV were associated (P < 0.05) with 20 and 17 conditions, and the direction of associations varied. Exercise was associated (P < 0.05) with reduced reporting of 8 conditions. CONCLUSIONS: Symptom burden is high in this group of breast cancer survivors, particularly following chemotherapy and in those who are overweight or obese. Health concerns vary by patient age and time since treatment. Exercise appears to attenuate patient-reported concerns. IMPLICATIONS FOR CANCER SURVIVORS: Survivorship care models should account for a variety of patient needs. Survivors who are overweight or obese and those who received chemotherapy appear to be at higher risk for adverse consequences of treatment.
PURPOSE: Survivorship care is an essential component in the management of cancerpatients. Optimal delivery of survivorship care requires an understanding of patient concerns and factors associated with treatment-related symptoms and comorbidities. METHODS: We conducted a retrospective cohort study evaluating 34 patient-reported conditions (symptoms and comorbidities) as well as self-reported health habits of stage 0-III breast cancerpatients using a questionnaire completed at the time of the initial survivorship visit (SV). Logistic regression analysis was used to assess effects of treatment, age, body mass index, health habits, and timing of SV on these 34 conditions. RESULTS: Data from 1126 patients seen between April 2009 and November 2015 were analyzed. Hot flashes/night sweats (44%) and numbness/tingling (34%) were the most commonly reported conditions. Significant associations (P < 0.05) were observed with chemotherapy and increased prevalence of 26 conditions, as well as higher BMI and increased prevalence of 10 conditions. Age and timing of SV were associated (P < 0.05) with 20 and 17 conditions, and the direction of associations varied. Exercise was associated (P < 0.05) with reduced reporting of 8 conditions. CONCLUSIONS: Symptom burden is high in this group of breast cancer survivors, particularly following chemotherapy and in those who are overweight or obese. Health concerns vary by patient age and time since treatment. Exercise appears to attenuate patient-reported concerns. IMPLICATIONS FOR CANCER SURVIVORS: Survivorship care models should account for a variety of patient needs. Survivors who are overweight or obese and those who received chemotherapy appear to be at higher risk for adverse consequences of treatment.
Entities:
Keywords:
Breast cancer survivor; Comorbidity; Exercise; Risk factors; Symptom
Authors: Catherine M Alfano; Kenneth L Lichstein; Gregory S Vander Wal; Ashley Wilder Smith; Bryce B Reeve; Anne McTiernan; Leslie Bernstein; Kathy B Baumgartner; Rachel Ballard-Barbash Journal: Breast Cancer Res Treat Date: 2011-05-13 Impact factor: 4.872
Authors: Shirley M Bluethmann; Sally W Vernon; Kelley Pettee Gabriel; Caitlin C Murphy; L Kay Bartholomew Journal: Breast Cancer Res Treat Date: 2015-01-03 Impact factor: 4.872
Authors: Ana Claudia Garabeli Cavalli Kluthcovsky; Almir Antonio Urbanetz; Denise Siqueira de Carvalho; Eliane Mara Cesario Pereira Maluf; Geovana Cristina Schlickmann Sylvestre; Sergio Bruno Bonatto Hatschbach Journal: Support Care Cancer Date: 2011-10-13 Impact factor: 3.603
Authors: Maura K Whiteman; Catherine A Staropoli; Patricia W Langenberg; Robert J McCarter; Kristen H Kjerulff; Jodi A Flaws Journal: Obstet Gynecol Date: 2003-02 Impact factor: 7.661
Authors: Cairu Li; Göran Samsioe; Christer Borgfeldt; Jonas Lidfeldt; Carl David Agardh; Christina Nerbrand Journal: Am J Obstet Gynecol Date: 2003-12 Impact factor: 8.661
Authors: Sebastian M Jud; Reinhard Hatko; Christian Maihöfner; Mayada R Bani; Michael G Schrauder; Michael P Lux; Matthias W Beckmann; Gassan Bani; Irina Eder; Peter A Fasching; Christian R Loehberg; Claudia Rauh; Alexander Hein Journal: Arch Gynecol Obstet Date: 2014-02-05 Impact factor: 2.344
Authors: Leah Cha; Amye J Tevaarwerk; Elena M Smith; Thevaa Chandereng; Karol J Huenerberg; Lori A Seaborne; Cibele B Carroll; Mary E Sesto Journal: J Cancer Educ Date: 2021-04-26 Impact factor: 2.037